Daniele G, Di Maio M, Piccirillo M. Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer: methodological comment:  . CBN [Internet]. 2014 Apr. 15 [cited 2024 Nov. 23];2(1):35-7. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/264